A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML.
Drenberg CD, Shelat A, Dang J, Cotton A, Orwick SJ, Li M, Jeon JY, Fu Q, Buelow DR, Pioso M, Hu S, Inaba H, Ribeiro RC, Rubnitz JE, Gruber TA, Guy RK, Baker SD.
Drenberg CD, et al. Among authors: li m.
Nat Commun. 2019 May 16;10(1):2189. doi: 10.1038/s41467-019-09917-0.
Nat Commun. 2019.
PMID: 31097698
Free PMC article.